News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Sherko Kümmel

Articles by Sherko Kümmel

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

ByLowell Hart,Seock-Ah Im,Sara M. Tolaney, MD, MPH,Mario Campone,Timothy Pluard,Berta Sousa,Gilles Freyer,Thomas Decker,Kevin Kalinsky, MD, MS,Astrid Thuerigen,Melissa Gao,Huilin Hu,Sherko Kümmel

August 9th 2024

32 Neoadjuvant Pembrolizumab or Placebo Plus Chemotherapy Followed by Adjuvant Pembrolizumab or Placebo for Early-Stage Triple- Negative Breast Cancer: Updated Event-Free Survival Results From the Phase 3 KEYNOTE-522 Study

Latest Updated Articles

Trending on CancerNetwork

Could Scorpion Venom Component Play a Role in Glioblastoma Management?

Evaluating the Viability of Antibody Drug Conjugates for Glioblastoma

FDA Approves Abbreviated NDA for Dasatinib Tablets in Leukemia Indications

What Were The Most Impactful GU Oncology Data From ESMO 2025?

FDA OKs Subcutaneous Daratumumab in High-Risk Smoldering Multiple Myeloma

© 2025 MJH Life Sciences^®

All rights reserved.